Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Patients with Large-Vessel Abnormalities Present Diagnostic Dilemma for Rheumatologists

Eli Miloslavsky, MD  |  Issue: February 2015  |  February 1, 2015

Marfan’s and Loeys-Dietz syndromes predominantly affect the aorta, which made these etiologies less likely in our patient. Although FMD preferentially affects the renal artery and can involve the iliacs, the typical “string of beads” appearance of the affected vessels, which is seen in approximately 90% of patients with FMD,2 was not seen on angiography, making this diagnosis less likely. In addition, FMD affects women in approximately 90% of cases, further arguing against this etiology.2 Our patient had no risk factors or imaging findings consistent with atherosclerotic disease. Therefore, we felt the most likely diagnoses were EDS IV or SAM.

EDS IV (vascular type) is a rare disorder that portends a significant risk of morbidity and mortality stemming from arterial or visceral rupture.3 Although EDS IV is inherited in an autosomal dominant pattern, studies suggest that approximately 50% of patients have de-novo mutations. In contrast to other types of EDS, large joint hypermobility is absent, although hyperextensibility of small joints can be observed in some patients. Other manifestations may include intestinal or uterine rupture, pneumothorax, translucent skin, characteristic facial appearance, acrogeria (aged appearance of the hands), tendon or muscle rupture, early onset of varicose veins and gingival recession.4 Eighty percent of patients are affected by the age of 40.3 Any large vessel can be affected in EDS IV, although the distal vessels of the extremities tend to be spared. The aorta, iliacs, renal, carotid and splanchnic vessels are most commonly affected.3 The diagnosis can be confirmed by testing for abnormalities in the COL3A1 gene, although some patients with EDS IV will not have detectable gene mutations.4

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Our patient had a pattern of vascular involvement compatible with EDS IV, as well as easily visible veins, perhaps suggesting skin translucency. Therefore, we pursued testing for abnormalities in the COL3A1 gene.

SAM is a rare noninflammatory vasculopathy, which leads to vacuolization of tissue in the outer portion of the media and separation of the media from the adventitia (“mediolysis”), ultimately leading to aneurysm and/or dissection. SAM can affect individuals of any age, but generally affects patients in the fifth to sixth decade of life, with a slight male predominance.5 The renal arteries (sometimes leading to renal infarcts), celiac and superior mesenteric arteries and their branches are most commonly affected; however, iliac artery involvement has also been reported.5 Because of the arteries involved, histologic confirmation of the diagnosis can be challenging, and frequently, the diagnosis relies on imaging findings of dissection and/or aneurysm in the appropriate vascular distribution and exclusion of other etiologies discussed previously. Notably, in light of our patient’s presentation, several authors have reported that SAM can evolve rapidly, involving multiple vascular beds in a matter of weeks.6

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsResearch RheumVasculitis Tagged with:AC&RAssociation of Rheumatology Professionals (ARP)AwardsLupus FoundationResearchSalmonTsokos

Related Articles
    Case Report: Ehlers-Danlos Syndrome Mimicking Vasculitis

    Case Report: Ehlers-Danlos Syndrome Mimicking Vasculitis

    July 19, 2018

    A 43-year-old man with a past medical history of type 2 diabetes mellitus, bilateral inguinal hernia repair as a child and prior cholecystectomy woke from sleep with sudden-onset periumbilical abdominal pain. He was admitted to another hospital, but required transfer to our surgical intensive care unit after a recurrent episode of severe abdominal pain, during…

    Fellow’s Forum Case Report: Takayasu’s Arteritis

    May 1, 2014

    How this rare form of large-vessel vasculitis affects different portions, branches of aorta and ways to diagnose, treat and manage the disease

    Study Finds Tocilizumab Could Be Treatment Option for Takayasu Arteritis

    August 17, 2018

    For patients with refractory Takayasu arteritis (TAK), glucocorticoids (GCs) are often provided as the initial therapy for treatment. However, GCs are often associated with adverse effects for long-term use; relapse also occurs frequently during GC tapering.1 TAK involves interleukin (IL) 6. Tocilizumab—a recombinant, humanized, anti-IL-6 receptor (IL-6R) monoclonal antibody—was first reported by Nishimoto et al….

    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    February 16, 2021

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences